Emerging evidence demonstrates that GLP-1 receptor agonists may provide significant benefits for liver health, particularly in patients with metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as non-alcoholic fatty liver disease or NAFLD) and its inflammatory subtype, metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH)
.,RamadhanAYRosdianaDSThe prospect of probiotics to treat metabolic syndrome.2024;8(2):7180 9
Your lawyer aims to secure an adequate settlement by accurately documenting your damages, including medical expenses, lost wages, and pain and suffering
By contrast, Dr
Although you cannot always shrink your pores, you can minimize the appearance of enlarged pores by keeping your skin clean and healthy with a quality skincare routine
N Engl J Med 2025;392:777-87.ArticlePubMed 118